These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30004841)

  • 1. Unlocking Human Brain Metabolism by Genome-Scale and Multiomics Metabolic Models: Relevance for Neurology Research, Health, and Disease.
    Sertbas M; Ulgen KO
    OMICS; 2018 Jul; 22(7):455-467. PubMed ID: 30004841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
    Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
    BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-scale, constraint-based approach to systems biology of human metabolism.
    Mo ML; Jamshidi N; Palsson BØ
    Mol Biosyst; 2007 Sep; 3(9):598-603. PubMed ID: 17700859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Kori M; Aydın B; Unal S; Arga KY; Kazan D
    OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big data in yeast systems biology.
    Yu R; Nielsen J
    FEMS Yeast Res; 2019 Nov; 19(7):. PubMed ID: 31603503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Scale Brain Metabolic Networks as Scaffolds for the Systems Biology of Neurodegenerative Diseases: Mapping Metabolic Alterations.
    Özcan E; Çakır T
    Adv Neurobiol; 2018; 21():195-217. PubMed ID: 30334223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of genome-scale metabolic models in evolutionary systems biology.
    Papp B; Szappanos B; Notebaart RA
    Methods Mol Biol; 2011; 759():483-97. PubMed ID: 21863504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Approaches to Assess Abnormal Metabolism in Alzheimer's Disease Using Transcriptomics.
    Lüleci HB; Uzuner D; Çakır T; Thambisetty M
    Methods Mol Biol; 2023; 2561():173-189. PubMed ID: 36399270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.
    Karki R; Kodamullil AT; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2019 Oct; 20(1):494. PubMed ID: 31604427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Modeling of Human Metabolism and Its Application to Systems Biomedicine.
    Aurich MK; Thiele I
    Methods Mol Biol; 2016; 1386():253-81. PubMed ID: 26677187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems Biology of Metabolism.
    Nielsen J
    Annu Rev Biochem; 2017 Jun; 86():245-275. PubMed ID: 28301739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems modeling of metabolic dysregulation in neurodegenerative diseases.
    Baloni P; Funk CC; Readhead B; Price ND
    Curr Opin Pharmacol; 2021 Oct; 60():59-65. PubMed ID: 34352486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the integration of transcriptional regulatory information into genome-scale metabolic models.
    Vivek-Ananth RP; Samal A
    Biosystems; 2016 Sep; 147():1-10. PubMed ID: 27287878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rise of Systems Glycobiology and Personalized Glycomedicine: Why and How to Integrate Glycomics with Multiomics Science?
    Kunej T
    OMICS; 2019 Dec; 23(12):615-622. PubMed ID: 31651212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape.
    Guo L; Zhong MB; Zhang L; Zhang B; Cai D
    Biol Psychiatry; 2022 Jan; 91(1):61-71. PubMed ID: 33896621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting novel pathways in genome-scale metabolic networks.
    Schuster S; de Figueiredo LF; Kaleta C
    Biochem Soc Trans; 2010 Oct; 38(5):1202-5. PubMed ID: 20863284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the reconstructed genome-scale human metabolic network to study physiology and pathology.
    Bordbar A; Palsson BO
    J Intern Med; 2012 Feb; 271(2):131-41. PubMed ID: 22142339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.